Digital Media briefs

Share this article:
Lundbeck launched a web-based Huntington's Disease awareness effort called Build Hope for HD. The campaign, launched to coincide with Huntington's Disease Awareness Month, partners Lundbeck with the Hereditary Disease Foundation and the Huntington Study Group. Lundbeck will donate $10 to the clinic for each click on the campaign icon at at

Facebook users are more likely to seek and share health advice, but people who frequent are generally more fit and health-conscious, according to a study by MicroMass. The study defined four archetypes: Power Socialites, who crave the spotlight and vamp on social media sites; Sincere Influentials, who maintain strong relationships with established friends, look for ways to improve the quality of their lives and favor and Craigslist, as well as Facebook; slovenly Solo Escapists who don't take care of themselves and like YouTube and; and Independent Achievers, fitness freaks who like MSNBC and MapQuest. launched My Epilepsy Diary, an iPhone app aimed at helping people with epilepsy manage seizures, symptoms and treatment.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?